Abstract
Background
Allograft–prosthesis composite (APC) for proximal femur reconstruction have shown favorable longevity and functional outcome compared to endoprosthesis, owing to restoration of bone stock, load-sharing property, and biological attachment of abductors and iliopsoas tendons.
Questions/purposes
This study examined whether a pasteurized-prosthesis composite (PPC) is comparable to APC regarding implant survival, functional outcome, and complication rates.
Patients and methods
We retrospectively reviewed 18 patients with proximal femur malignancy that underwent reconstruction with a cemented pasteurized autograft–prosthesis composite between 1993 and 2008. We evaluated implant survival (Kaplan–Meier), functional outcome (MSTS score), complications and secondary operations.
Results
The estimated survival rate of the 18 composites was 86% at 5 and 10 years. Within a mean follow-up of 93 months (median 113, range 14–163) two composites (11%) were removed due to un-resolving infection. The mean MSTS functional score of surviving 16 composites was 80% (range 70–95). Non-union and stem loosening in host bone were identified in a single patient, while infection developed in two patients. THA conversion occurred in three composites due to secondary osteoarthritis in two, and subluxation in one case. Two of the six cases, with greater trochanter (GT) reconstruction, showed GT avulsion. No autograft was fractured.
Conclusions
Pasteurized autograft–prosthesis composite (PPC) of the proximal femur has comparable survival rate, functional outcome, and complication rates to allograft–prosthesis composite (APC), thereby offering an alternative reconstructive option for proximal femoral reconstruction.
Similar content being viewed by others
References
Anract P, Coste J, Vastel L, Jeanrot C, Mascard E, Tomeno B (2000) Proximal femoral reconstruction with megaprosthesis versus allograft prosthesis composite: a comparative study of functional results, complications and longevity in 41 cases. Rev Chir Orthop Reparatrice Appar Mot 86(3):278–288
Berrey BH, Lord CF, Gebhardt MC, Mankin HJ (1990) Fractures of allografts. Frequency, treatment, and end-results. J Bone Jt Surg Am 72(6):825–833
Biau DJ, Larousserie F, Thevenin F, Piperno-Neumann S, Anract P (2010) Results of 32 allograft–prosthesis composite reconstructions of the proximal femur. Clin Orthop Relat Res 468(3):834–845
Buck BE, Malinin TI, Brown MD (1989) Bone transplantation and human immunodeficiency virus: an estimate of risk of acquired immunodeficiency syndrome (AIDS). Clin Orthop Relat Res 240:129–136
Chandrasekar CR, Grimer RJ, Carter SR, Tillman RM, Abudu A, Buckley L (2009) Modular endoprosthetic replacement for tumours of the proximal femur. J Bone Jt Surg Br 91-B:108–112
Damron TA, Sim FH (2009) Surgical treatment for metastatic disease of the pelvis and the proximal end of the femur. Instr Course Lect 49:461–470
Donati D, Giacomini S, Gozzi E, Mercuri M (2002) Proximal femur reconstruction by an allograft prosthesis composite. Clin Orthop Relat Res 394:192–200
Donati D, Zavatta M, Gozzi E, Giacomini S, Campanacci L, Mercuri M (2001) Modular prosthetic replacement of the proximal femur after resection of a bone tumour. A long-term follow-up. J Bone Jt Surg Br 83-B:1156–1160
Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ (1993) A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res 286:241–246
Enneking WF, Spanier SS, Goodman MA (1980) A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 153:106–120
Farid Y, Lin PP, Lewis VO, Yasko AW (2006) Endoprosthetic and allograft-prosthetic composite reconstruction of the proximal femur for bone neoplasms. Clin Orthop Relat Res 442:223–229
Finstein JL, King JJ, Fox EJ, Ogilvie CM, Lackman RD (2007) Bipolar proximal femoral replacement prostheses for musculoskeletal neoplasms. Clin Orthop Relat Res 459:66–75
Fox EJ, Hau MA, Gebhardt MC, Hornicek FJ, Tomford WW, Mankin HJ (2002) Long-term follow-up of proximal femoral allografts. Clin Orthop Relat Res 397:106–113
Friedlaender GE, Strong DM, Tomford WW, Mankin HJ (1991) Long term follow-up of patients with osteochondral allografts. A correlation between immunologic responses and clinical outcome. Orthop Clin North Am 30:583
Gitelis S, Heligman D, Quill G, Piasecki P (1988) The use of large allografts for tumor reconstruction and salvage of the failed total hip arthroplasty. Clin Orthop Relat Res 231:62–70
Greene FL, Page DL, Flemming FD (2002) American Joint Committee on Cancer: cancer staging manual. Springer, New York
Hardes J, Gebert C, Schwappach A, Ahrens H, Streitburger A, Winkelmann W, Gosheger G (2006) Characteristics and outcome of infections associated with tumor endoprostheses. Arch Orthop Trauma Surg 126:289–296
Hejna MJ, Gitelis S (1997) Allograft–prosthetic composite replacement for bone tumors. Semin Surg Oncol 13:18–24
Hornicek FJ, Gebhardt MC, Tomford WW, Sorger JI, Zavatta M, Menzner JP, Mankin HJ (2001) Factors affecting nonunion of the allograft–host junction. Clin Orthop Relat Res 382:87–98
Jeon DG, Kim MS, Cho WH, Song WS, Lee SY (2007) Pasteurized autograft for intercalary resection: an alternative to allograft. Clin Orthop Relat Res 456:203–210
Jeon DG, Kim MS, Cho WH, Song WS, Lee SY (2007) Pasteurized autograft–prosthesis composite for distal femoral osteosarcoma. J Orthop Sci 12(6):542–549
Jeon DG, Kim MS, Cho WH, Song WS, Lee SY (2007) Pasteurized autograft–prosthesis composite for reconstruction of proximal tibia in 13 sarcoma patients. J Surg Oncol 96(7):590–597
Jeon DG, Kim MS, Cho WH, Song WS, Lee SY (2007) Reconstruction with pasteurized autograft–total hip prosthesis composite for periacetabular tumors. J Surg Oncol 96(6):493–502
Jeys LM, Grimer RJ, Carter SR, Tillman RM (2005) Periprosthetic infection in patients treated for an orthopaedic oncological condition. J Bone Jt Surg Am 87:842–849
Jofe MH, Gebhardt MC, Tomford WW, Mankin HJ (1988) Reconstruction for defects of the proximal part of the femur using allograft arthroplasty. J Bone Jt Surg Am 70(4):507–516
Langlais F, Lambotte JC, Collin P, Thomazeau H (2003) Long-term results of allograft composite total hip prostheses for tumors. Clin Orthop Relat Res 414:197–211
Manabe J, Ahmed AR, Kawaguchi N, Matsumoto S, Kuroda H (2004) Pasteurized autologous bone graft in surgery for bone and soft tissue sarcoma. Clin Orthop Relat Res 419:258–266
Mankin HJ, Hornicek FJ, Raskin KA (2005) Infection in massive bone allografts. Clin Orthop Relat Res 432:210–216
Masterson EL, Ferracini R, Griffin AM, Wunder JS, Bell RS (1998) Capsular replacement with synthetic mesh: effectiveness in preventing postoperative dislocation after wide resection of the proximal femoral tumors and prosthetic reconstruction. J Arthroplast 13:860–866
McGoveran BM, Davis AM, Gross AE, Bell RS (1999) Evaluation of the allograft–prosthesis composite technique for proximal femoral reconstruction after resection of a primary bone tumour. Can J Surg 42:37–45
Menendez LR, Ahlmann ER, Kermani C, Gotha H (2006) Endoprosthetic reconstruction for neoplasms of the proximal femur. Clin Orthop Relat Res 450:46–51
Rosen G, Marcove RC, Huvos AG, Caparros BI, Lane JM, Nirenberg A, Cacavio A, Groshen S (1983) Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy. J Cancer Res Clin Oncol 106:55–67
Sakayama K, Kidani T, Fujibuchi T, Kamogawa J, Yamamoto H, Shibata T (2004) Reconstruction surgery for patients with musculoskeletal tumor, using a pasteurized autogenous bone graft. Int J Clin Oncol 9:167–173
Schneiderbauer MM, Von-Knoch M, Schleck CD, Harmsen WS, Sim FH, Scully SP (2004) Patient survival after hip arthroplasty for metastatic disease of the hip. J Bone Jt Surg Am 86:1684–1689
Wirganowicz PZ, Eckardt JJ, Dorey FJ, Eilber FR, Kabo JM (1999) Etiology and results of tumor endoprosthesis revision surgery in 64 patients. Clin Orthop Relat Res 358:64–74
Zehr RJ, Enneking WF, Scarborough MT (1996) Allograft–prosthesis composite versus megaprosthesis in proximal femoral reconstruction. Clin Orthop Relat Res 322:207–223
Conflict of interest
Each author certifies that he or she has no commercial associations (e.g., consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eid, A.S., Jeon, DG., Song, W.S. et al. Pasteurized autograft–prosthesis composite for proximal femoral reconstruction: an alternative to allograft composite. Arch Orthop Trauma Surg 131, 729–737 (2011). https://doi.org/10.1007/s00402-010-1194-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00402-010-1194-0